Home

Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 25/04/10

Trade details

Type
Insider sale
Amount
$898,581.24
Shares · price
9,628 sh · $93.33 a share
Held after
13,283 sh
Trade date
25/04/09
Filed
25/04/10
Days to filing
1 days

Sold 42.0% of holdings

Share of holding sold
42.0%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 25/03/10~25/05/09

Katherine Stueland's recent trades

  • Katherine Stueland

    Planned saleGeneDx Holdings

    $1.2M

    Filed 09/01

  • Katherine Stueland

    SellGeneDx Holdings

    $360.8K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $149.4K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $127.9K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $195.7K

    Filed 06/11

Katherine Stueland, CEO — sold $898.6K of GeneDx Holdings WGS · 42.0% of holdings · 10b5-1 plan | Whalegun